Department of Thoracic Surgery, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou, Henan, 450003, China.
Cell Cycle. 2021 Jun;20(12):1163-1172. doi: 10.1080/15384101.2021.1929675. Epub 2021 May 31.
This study aimed to explore the role of micorRNA-2053 in esophageal cancer development. The expression level of miR-2053 in esophageal cancer cell lines was detected. After cell transfection, the effects of miR-2053 overexpression on proliferation, apoptosis, migration and invasion of esophageal cancer cells were determined. Moreover, the potential molecular mechanism was explored by measuring the epithelial-mesenchymal transition (EMT) and apoptosis-related proteins. Luciferase reporter assay was conducted to investigate the target gene of miR-2053. The protein expressions of PI3K/AKT pathway associated factors were detected after overexpression of miR-2053 or administration with the pathway inhibitor LY294002. The miR-2053 was downregulated in esophageal cancer cell lines. Overexpression of miR-2053 inhibited cell proliferation, migration and invasion while promoted apoptosis. Molecular mechanism elucidated that miR-2053 could reduce EMT and elevate the expression of pro-apoptotic proteins. Further study found that overexpressed miR-2053 could negatively regulate KIF3C and involve in PI3K/AKT signaling pathway. Our study demonstrated the downregulation of miR-2053 in esophageal cancer. Downregulation of miR-2053 involved in the proliferation, apoptosis, migration and invasion of esophageal cancer cells through upregulating KIF3C expression and activating the PI3K/AKT signaling pathway. miR-2053 may have the potential in clinical treatment of esophageal cancer.
本研究旨在探讨 microRNA-2053 在食管癌发展中的作用。检测食管癌细胞系中 miR-2053 的表达水平。转染细胞后,确定 miR-2053 过表达对食管癌细胞增殖、凋亡、迁移和侵袭的影响。此外,通过测量上皮-间充质转化(EMT)和凋亡相关蛋白来探讨潜在的分子机制。通过荧光素酶报告基因检测来研究 miR-2053 的靶基因。过表达 miR-2053 或给予 PI3K/AKT 通路抑制剂 LY294002 后,检测 PI3K/AKT 通路相关因子的蛋白表达。miR-2053 在食管癌细胞系中下调。miR-2053 的过表达抑制细胞增殖、迁移和侵袭,同时促进凋亡。分子机制表明,miR-2053 可以减少 EMT 并上调促凋亡蛋白的表达。进一步的研究发现,过表达的 miR-2053 可以负调控 KIF3C 并参与 PI3K/AKT 信号通路。本研究表明 miR-2053 在食管癌中下调。miR-2053 的下调通过上调 KIF3C 表达和激活 PI3K/AKT 信号通路参与食管癌细胞的增殖、凋亡、迁移和侵袭。miR-2053 可能具有治疗食管癌的临床潜力。